This publication is a summary of a recent presentation by Professor David Gottlieb, Professor
of Haematology at Westmead Clinical School, Westmead Millennium Institute for Medical
Research, Westmead Hospital, University of Sydney, Australia.
He spoke to medical oncologists, haematologists and oncology registrars in Auckland in October
2010 about chronic lymphocytic leukaemia and beyond immunochemotherapy with the use of
fludarabine, cyclophosphamide and rituximab.
Download PDF